<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02466529</url>
  </required_header>
  <id_info>
    <org_study_id>SMA-NHR10311</org_study_id>
    <nct_id>NCT02466529</nct_id>
  </id_info>
  <brief_title>Natural History of Spinal Muscular Atrophy Type 1 in Taiwan</brief_title>
  <official_title>Natural History of Spinal Muscular Atrophy Type 1 in Taiwan</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biogen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University WanFang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Veterans General Hospital, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mackay Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chang Gung Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhua Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chi Mei Medical Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cathay General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shin Kong Wu Ho-Su Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaohsiung Veterans General Hospital.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Buddhist Tzu Chi General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaohsiung Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University Shuang Ho Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by
      degeneration of motor neurons in the spinal cord and caused by mutations of the survival
      motor neuron 1 (SMN1) gene.

      The investigators will conduct a systematic review of the contents and activities collected
      via a comprehensive case report form. Patients who fulfilled diagnostic criteria for SMA type
      1 will be reviewed retrospectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to investigate the natural history of patients with
      spinal muscular atrophy (SMA) type 1 in Taiwan. This study will provide further insights into
      the clinical course and pathogenesis of SMA. Several analyses will be conducted regarding
      overall survival, respiratory support, feeding and nutritional support. The following outcome
      variables will be examined: correlation between SMA genotype and phenotype, survival, age of
      onset, and age of confirmed diagnosis, proportion of patients using non-invasive and invasive
      respiratory support, time to first use of respiratory support, proportion of patients on
      permanent ventilation, and time to permanent ventilation, number and average duration of
      hospitalizations, proportion of patients with gastrostomy, number of non-serious and serious
      respiratory infections, trend of growth parameter (e.g., body weight).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Age of death</measure>
    <time_frame>up to 36 years</time_frame>
    <description>participants will be followed till the age of death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Age of permanent ventilation</measure>
    <time_frame>up to 36 years</time_frame>
    <description>participants will be followed till ventilation used 24 hours/day</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Clinical outcome with the following measures-1</measure>
    <time_frame>up to 36 years</time_frame>
    <description>Age of onset</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical outcome with the following measures-2</measure>
    <time_frame>up to 36 years</time_frame>
    <description>Copy numbers of SMN2 gene</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical outcome with the following measures-3</measure>
    <time_frame>up to 36 years</time_frame>
    <description>Methods of Nutritional Supportive</description>
  </other_outcome>
  <other_outcome>
    <measure>Clinical outcome with the following measures-4</measure>
    <time_frame>up to 36 years</time_frame>
    <description>Methods of Respiratory Supportive</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">111</enrollment>
  <condition>Natural History of Type 1 Spinal Muscular Atrophy (SMA)</condition>
  <arm_group>
    <arm_group_label>type 1 spinal muscular atrophy</arm_group_label>
    <description>The age of onset of patients with type 1 SMA is below 6 months of age.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Spinal muscular atrophy Type 1
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Jan. 1979~ 30 Jun. 2014 diagnosed with Spinal Muscular Atrophy (SMA)Type 1

          -  Onset of paralytic floppy infant less than 6 months of age

          -  Generalized hypotonia and symmetric weakness, which weakness is more severe in
             proximal than distal part of extremities

          -  Weakness in the legs is greater than in the arms

          -  Tendon reflexes are absent

          -  Neurogenic changes in electromyogram and/or muscle pathology

          -  SMN1 gene deletion or mutation

        Exclusion Criteria:

          -  Non-5q SMA (no deletion or mutation of SMN1 gene)

          -  SMA type 2, type 3 or type 4 (onset of SMA after 6 months of age)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2015</study_first_submitted>
  <study_first_submitted_qc>June 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2015</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type 1 spinal muscular atrophy (SMA)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

